These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 27439614)
1. Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas. Maekawa A; Kohashi K; Kuda M; Iura K; Ishii T; Endo M; Nakatsura T; Iwamoto Y; Oda Y BMC Cancer; 2016 Jul; 16():511. PubMed ID: 27439614 [TBL] [Abstract][Full Text] [Related]
2. Expression of Forkhead box M1 in soft tissue leiomyosarcoma: Clinicopathologic and in vitro study using a newly established cell line. Maekawa A; Kohashi K; Setsu N; Kuda M; Iura K; Ishii T; Matsunobu T; Nakatsura T; Iwamoto Y; Oda Y Cancer Sci; 2016 Jan; 107(1):95-102. PubMed ID: 26560505 [TBL] [Abstract][Full Text] [Related]
3. The forkhead box M1 (FOXM1) expression and antitumor effect of FOXM1 inhibition in malignant rhabdoid tumor. Shibui Y; Kohashi K; Tamaki A; Kinoshita I; Yamada Y; Yamamoto H; Taguchi T; Oda Y J Cancer Res Clin Oncol; 2021 May; 147(5):1499-1518. PubMed ID: 33221995 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of forkhead box M1 (FoxM1) expression and antitumour effect of FoxM1 inhibition in melanoma. Ito T; Kohashi K; Yamada Y; Maekawa A; Kuda M; Furue M; Oda Y Histopathology; 2016 Jul; 69(1):63-71. PubMed ID: 26619071 [TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells. Kongsema M; Wongkhieo S; Khongkow M; Lam EW; Boonnoy P; Vongsangnak W; Wong-Ekkabut J Oncol Rep; 2019 Sep; 42(3):953-962. PubMed ID: 31322278 [TBL] [Abstract][Full Text] [Related]
6. Identification of FOXM1 as a specific marker for triple‑negative breast cancer. Tan Y; Wang Q; Xie Y; Qiao X; Zhang S; Wang Y; Yang Y; Zhang B Int J Oncol; 2019 Jan; 54(1):87-97. PubMed ID: 30365046 [TBL] [Abstract][Full Text] [Related]
7. Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer. Weiler SME; Pinna F; Wolf T; Lutz T; Geldiyev A; Sticht C; Knaub M; Thomann S; Bissinger M; Wan S; Rössler S; Becker D; Gretz N; Lang H; Bergmann F; Ustiyan V; Kalin TV; Singer S; Lee JS; Marquardt JU; Schirmacher P; Kalinichenko VV; Breuhahn K Gastroenterology; 2017 Jun; 152(8):2037-2051.e22. PubMed ID: 28249813 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of Forkhead box protein M1 by thiostrepton increases chemosensitivity to doxorubicin in T-cell acute lymphoblastic leukemia. Wang JY; Jia XH; Xing HY; Li YJ; Fan WW; Li N; Xie SY Mol Med Rep; 2015 Jul; 12(1):1457-64. PubMed ID: 25760224 [TBL] [Abstract][Full Text] [Related]
9. Forkhead box M1 (FOXM1) expression predicts disease free survival and may mediate resistance to chemotherapy and hormonotherapy in male breast cancer. Abdeljaoued S; Bettaieb L; Nasri M; Adouni O; Goucha A; Bouzaiene H; Boussen H; Rahal K; Gamoudi A Breast Dis; 2018; 37(3):109-114. PubMed ID: 29504520 [TBL] [Abstract][Full Text] [Related]
10. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma. Jiang L; Wu X; Wang P; Wen T; Yu C; Wei L; Chen H J Cancer Res Clin Oncol; 2015 Jun; 141(6):971-81. PubMed ID: 25391371 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of forkhead box protein M1 (FOXM1) plays a critical role in colorectal cancer. Zhang HG; Xu XW; Shi XP; Han BW; Li ZH; Ren WH; Chen PJ; Lou YF; Li B; Luo XY Clin Transl Oncol; 2016 May; 18(5):527-32. PubMed ID: 26370421 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer. Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of FoxM1 by thiostrepton or small interfering RNA inhibits proliferation, transformation ability and angiogenesis, and induces apoptosis of nasopharyngeal carcinoma cells. Jiang L; Wang P; Chen L; Chen H Int J Clin Exp Pathol; 2014; 7(9):5450-60. PubMed ID: 25337187 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of expression of cancer stem cell markers and fusion gene in synovial sarcoma: Insights into histogenesis and pathogenesis. Zhou Y; Chen D; Qi Y; Liu R; Li S; Zou H; Lan J; Ju X; Jiang J; Liang W; Shen Y; Pang L; Li F Oncol Rep; 2017 Jun; 37(6):3351-3360. PubMed ID: 28498445 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of FOXM1 by thiostrepton sensitizes medulloblastoma to the effects of chemotherapy. Lin J; Zheng Y; Chen K; Huang Z; Wu X; Zhang N Oncol Rep; 2013 Oct; 30(4):1739-44. PubMed ID: 23912794 [TBL] [Abstract][Full Text] [Related]
16. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells. Hamurcu Z; Ashour A; Kahraman N; Ozpolat B Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606 [TBL] [Abstract][Full Text] [Related]
17. FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target. Kuda M; Kohashi K; Yamada Y; Maekawa A; Kinoshita Y; Nakatsura T; Iwamoto Y; Taguchi T; Oda Y Tumour Biol; 2016 Apr; 37(4):5213-23. PubMed ID: 26553361 [TBL] [Abstract][Full Text] [Related]
18. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression. Kwok JM; Myatt SS; Marson CM; Coombes RC; Constantinidou D; Lam EW Mol Cancer Ther; 2008 Jul; 7(7):2022-32. PubMed ID: 18645012 [TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of Forkhead Box M1 (FOXM1) Expression and Antitumor Effect of FOXM1 Inhibition in Angiosarcoma. Ito T; Kohashi K; Yamada Y; Iwasaki T; Maekawa A; Kuda M; Hoshina D; Abe R; Furue M; Oda Y J Cancer; 2016; 7(7):823-30. PubMed ID: 27162541 [TBL] [Abstract][Full Text] [Related]
20. Targeting FOXM1 Improves Cytotoxicity of Paclitaxel and Cisplatinum in Platinum-Resistant Ovarian Cancer. Westhoff GL; Chen Y; Teng NNH Int J Gynecol Cancer; 2017 Oct; 27(8):1602-1609. PubMed ID: 28692634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]